Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING
JIB

Optoelectrokinetic Tech Underlies New Biochip Approach

By BiotechDaily International staff writers
Posted on 05 Feb 2013
Image: Researchers have demonstrated a new technology that combines a laser and electric fields to create tiny centrifuge-like whirlpools to separate particles and microbes by size, a potential lab-on-a-chip system for medicine and research. Here the technique is used to collect a bacterium called Shewanella oneidensis (Photo courtesy of Purdue University).
Image: Researchers have demonstrated a new technology that combines a laser and electric fields to create tiny centrifuge-like whirlpools to separate particles and microbes by size, a potential lab-on-a-chip system for medicine and research. Here the technique is used to collect a bacterium called Shewanella oneidensis (Photo courtesy of Purdue University).
Image: Here the rapid electrokinetic patterning technique is used to arrange bacteria into a specific pattern. The technique may be used as a tool for nanomanufacturing because it shows promise for the assembly of suspended particles, called colloids. The ability to construct objects with colloids makes it possible to create structures with particular mechanical and thermal characteristics to manufacture electronic devices and tiny mechanical parts (Photo courtesy of Purdue University).
Image: Here the rapid electrokinetic patterning technique is used to arrange bacteria into a specific pattern. The technique may be used as a tool for nanomanufacturing because it shows promise for the assembly of suspended particles, called colloids. The ability to construct objects with colloids makes it possible to create structures with particular mechanical and thermal characteristics to manufacture electronic devices and tiny mechanical parts (Photo courtesy of Purdue University).
A recently developed optoelectrokinetic manipulation technique was used to separate microorganisms according to size, which demonstrated the potential of this method for the development of "lab-on-a-chip" diagnostic technologies.

The technique, rapid electrokinetic patterning - or REP, works by focusing an infrared laser to heat a fluid in a microchannel containing particles or bacteria. An electric field is applied that combined with the laser's heating action causes the fluid to circulate in a "microfluidic vortex" that functions like a centrifuge to isolate particles based on size.

A detailed description of the method, which was used to collect three different types of microorganisms: the bacterium Shewanella oneidensis MR-1; the single-cell spherical fungus Saccharomyces cerevisiae; and the spherical bacterium Staphylococcus aureus, was published in the December 7, 2012, issue of the journal Lab on a Chip.

Senior author Dr. Steven T. Wereley, professor of mechanical engineering at Purdue University (West Lafayette, IN, USA), said, "By properly choosing the electrical frequency we can separate blood components, such as platelets. Say you want to collect Shewanella bacteria, so you use a certain electrical frequency and collect them. Then the next day you want to collect platelets from blood. That is going to be a different frequency. We foresee the ability to dynamically select what you will collect, which you could not do with conventional tools. The new results demonstrate that REP can be used to sort biological particles but also that the technique is a powerful tool for development of a high-performance on-chip bioassay system."

"It will not be on the market in a year," said Dr. Wereley. "We are still in the research end of this. We are sort of at the stage of looking for the killer app for this technology."

The REP method may also have applications in the field of nanomanufacturing due to its ability to assemble suspensions of particles known as colloids. This may be particularly relevant to the pharmaceutical industry, as a number of drugs are manufactured from solid particles suspended in liquid. Currently particles are collected and separated from the liquid by a process of filtration and centrifugation—methods not now available for production use at the nano level.

Related Links:

Purdue University



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Differences in the structure of a small lung artery (top row) and heart cross section (lower row) of rodents without disease (far left column); with pulmonary hypertension (middle) and a diseased rodent treated with the HDL peptide (right). Note the much narrowed lung artery, and thick walls and larger chamber of the heart in the diseased animal and improvements with 4F peptide treatment (Photo courtesy of UCLA - University of California, Los Angeles).

Apolipoprotein A-1 Mimetic Peptide Reverses Pulmonary Hypertension in Rodent Models

A small peptide that mimics the activity of apolipoprotein A-1 (apo A-1), the main protein component of the high density lipoproteins (HDL), counteracted the effects of oxidized lipids and alleviated symptoms... Read more

Drug Discovery

view channel
Image: The five stages of biofilm development: (1) Initial attachment, (2) Irreversible attachment, (3) Maturation I, (4) Maturation II, and (5) Dispersion. Each stage of development in the diagram is paired with a photomicrograph of a developing P. aeruginosa biofilm. All photomicrographs are shown to same scale (Photo courtesy of Wikimedia Commons).

Ionic Liquids Disperse Bacterial Biofilms and Increase Antibiotic Susceptibility

The ionic liquid choline-geranate was shown to effectively eliminate the protective biofilm generated by bacteria such as Salmonella enterica and Pseudomonas aeruginosa and to significantly increase the... Read more

Therapeutics

view channel
Image: Hair follicle (blue) being attacked by T cells (green) (Photo courtesy of Christiano Lab/Columbia University Medical Center).

Hair Restoration Method Clones Patients’ Cells to Grow New Hair Follicles

Researchers have developed of a new hair restoration approach that uses a patient’s cells to grow new hair follicles. In addition, the [US] Food and Drugs Administration (FDA) recently approved a new drug... Read more

Business

view channel

Partnership Established to Decode Bowel Disease

23andMe (Mountain View, CA,USA), a personal genetics company, is collaborating with Pfizer, Inc. (New York, NY, USA), in which the companies will seek to enroll 10,000 people with inflammatory bowel disease (IBD) in a research project designed to explore the genetic factors associated with the onset, progression, severity,... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.